DK3274710T3 - Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer - Google Patents
Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer Download PDFInfo
- Publication number
- DK3274710T3 DK3274710T3 DK16716342.7T DK16716342T DK3274710T3 DK 3274710 T3 DK3274710 T3 DK 3274710T3 DK 16716342 T DK16716342 T DK 16716342T DK 3274710 T3 DK3274710 T3 DK 3274710T3
- Authority
- DK
- Denmark
- Prior art keywords
- pitles
- photor
- rpe
- progenitors
- receptor
- Prior art date
Links
- 238000003556 assay Methods 0.000 title 1
- 239000000790 retinal pigment Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562136660P | 2015-03-23 | 2015-03-23 | |
PCT/US2016/023839 WO2016154357A1 (en) | 2015-03-23 | 2016-03-23 | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3274710T3 true DK3274710T3 (da) | 2021-09-06 |
Family
ID=55752717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16716342.7T DK3274710T3 (da) | 2015-03-23 | 2016-03-23 | Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer |
Country Status (16)
Country | Link |
---|---|
US (3) | US11422125B2 (da) |
EP (3) | EP4343331A2 (da) |
JP (3) | JP6902474B2 (da) |
KR (2) | KR20230132893A (da) |
CN (2) | CN107889507B (da) |
AU (2) | AU2016235176B2 (da) |
CA (2) | CA2980580C (da) |
DK (1) | DK3274710T3 (da) |
ES (1) | ES2877400T3 (da) |
HU (1) | HUE054946T2 (da) |
IL (3) | IL293110B2 (da) |
MX (2) | MX2017012259A (da) |
PL (1) | PL3274710T3 (da) |
PT (1) | PT3274710T (da) |
SG (3) | SG11201707775TA (da) |
WO (1) | WO2016154357A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012012803A2 (en) | 2010-07-23 | 2012-01-26 | Advanced Cell Technology, Inc. | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
PT3274710T (pt) | 2015-03-23 | 2021-07-06 | Astellas Inst For Regenerative Medicine | Ensaios melhorados para potência de células de epitélio pigmentar da retina (rpe) humana e de progenitoras de fotorrecetores |
SG10201913250SA (en) | 2015-08-18 | 2020-03-30 | Astellas Inst For Regenerative Medicine | Clinical formulations |
IL292610A (en) | 2019-10-30 | 2022-07-01 | Astellas Inst For Regenerative Medicine | Methods for the production of retinal pigment epithelial cells |
DE102022103893A1 (de) * | 2022-02-18 | 2023-08-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
MXPA01013450A (es) | 1999-06-30 | 2003-09-04 | Advanced Cell Tech Inc | Transferencia citoplasmica para celulas receptoras de-diferenciacion. |
US20040180430A1 (en) | 1999-09-07 | 2004-09-16 | West Michael D. | Methods of restoring telomere length and extending cell lifespan using nuclear transfer |
WO2001018236A1 (en) | 1999-09-07 | 2001-03-15 | Advanced Cell Technology, Inc. | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
US20050255596A1 (en) | 1999-09-07 | 2005-11-17 | West Michael D | Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer |
JP2003512848A (ja) | 1999-11-02 | 2003-04-08 | ユニバーシティ オブ マサチューセッツ、アズ リプリゼンティッド バイ イッツ アマースト キャンパス | 遺伝的診断、修飾および増殖のための一倍体ゲノムの使用 |
EP1241936A4 (en) | 1999-12-20 | 2006-04-05 | Anthony C F Perry | PROCESS FOR PRODUCING EMBRYOS AND CLONED ADULTS FROM CULTIVATED CELLS |
CA2394614A1 (en) | 1999-12-20 | 2001-06-28 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Embryonic or stem-like cells produced by cross species nuclear transplantation |
US20020132346A1 (en) | 2001-03-08 | 2002-09-19 | Jose Cibelli | Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
WO2002073188A1 (en) | 2001-03-13 | 2002-09-19 | Advanced Cell Technology, Inc. | Method for generating replacement cells and/or tissues |
CA2458575C (en) | 2001-08-24 | 2014-07-08 | Advanced Cell Technology, Inc. | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
WO2004060056A2 (en) | 2002-12-27 | 2004-07-22 | Advanced Cell Technology, Inc. | Sperm-induced cellular activation |
CA2552288C (en) | 2004-01-02 | 2015-02-24 | Advanced Cell Technology, Inc. | Novel culture systems for ex vivo development |
US20190282622A1 (en) | 2004-01-23 | 2019-09-19 | Astellas Institute For Regenerative Medicine | Modalities for the treatment of degenerative diseases of the retina |
US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
EP4248752A3 (en) | 2004-01-23 | 2024-01-03 | President And Fellows Of Harvard College | Improved modalities for the treatment of degenerative diseases of the retina |
GB0407836D0 (en) | 2004-04-06 | 2004-05-12 | Univ Cambridge Tech | Fluorescent dyes and complexes |
AU2005304978A1 (en) | 2004-11-04 | 2006-05-18 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
US20060263338A1 (en) | 2005-03-04 | 2006-11-23 | Jacoby Douglas B | Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
US8889122B2 (en) | 2005-05-09 | 2014-11-18 | Mytogen, Inc. | Cellular cardiomyoplasty as supportive therapy in patients with heart disease |
ES2933478T3 (es) | 2005-08-03 | 2023-02-09 | Astellas Inst For Regenerative Medicine | Métodos mejorados de reprogramación de células somáticas animales |
US20090271335A1 (en) | 2005-10-20 | 2009-10-29 | Advanced Cell Technology, Inc. | Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigent Genes |
EP2612906A3 (en) | 2006-05-03 | 2013-12-11 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
EP3190178A1 (en) | 2007-02-23 | 2017-07-12 | Astellas Institute for Regenerative Medicine | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
PL2209888T3 (pl) | 2007-10-12 | 2020-05-18 | Astellas Institute For Regenerative Medicine | Ulepszony sposób wytwarzania komórek rpe i kompozycji komórek rpe |
US20110028780A1 (en) | 2007-12-19 | 2011-02-03 | Robert Lanza | Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom |
KR20120102709A (ko) | 2009-11-17 | 2012-09-18 | 어드밴스드 셀 테크놀로지, 인코포레이티드 | 인간 rpe 세포의 생산 방법 및 인간 rpe 세포의 제약 제제 |
WO2012012803A2 (en) | 2010-07-23 | 2012-01-26 | Advanced Cell Technology, Inc. | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
US20120184035A1 (en) | 2011-01-13 | 2012-07-19 | Sadhana Agarwal | Methods and Compositions For Reprogramming Cells |
IL308205A (en) | 2011-11-14 | 2024-01-01 | Astellas Inst For Regenerative Medicine | Pharmaceutical preparations of human RPE cells and their use |
US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
LT2785359T (lt) | 2011-11-30 | 2018-11-12 | Astellas Institute For Regenerative Medicine | Mezenchiminės stromos ląstelės ir su jomis susiję naudojimo būdai |
CA3178138A1 (en) | 2011-12-06 | 2013-06-13 | Astellas Institute For Regenerative Medicine | Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof |
US9511152B2 (en) | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
US9763984B2 (en) | 2012-12-21 | 2017-09-19 | Astellas Institute For Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
US20160175362A1 (en) | 2014-03-14 | 2016-06-23 | Ocata Therapeutics, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
US20160175361A1 (en) | 2014-03-14 | 2016-06-23 | Advanced Cell Technology, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
US11241460B2 (en) | 2013-03-15 | 2022-02-08 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
PT2970903T (pt) | 2013-03-15 | 2024-02-26 | Astellas Inst For Regenerative Medicine | Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes |
PT3189135T (pt) | 2014-09-05 | 2021-08-19 | Astellas Inst For Regenerative Medicine | Células ganclionares retinianas e seus progenitores |
PT3274710T (pt) | 2015-03-23 | 2021-07-06 | Astellas Inst For Regenerative Medicine | Ensaios melhorados para potência de células de epitélio pigmentar da retina (rpe) humana e de progenitoras de fotorrecetores |
SG10201913250SA (en) | 2015-08-18 | 2020-03-30 | Astellas Inst For Regenerative Medicine | Clinical formulations |
-
2016
- 2016-03-23 PT PT167163427T patent/PT3274710T/pt unknown
- 2016-03-23 IL IL293110A patent/IL293110B2/en unknown
- 2016-03-23 EP EP24154934.4A patent/EP4343331A2/en active Pending
- 2016-03-23 CA CA2980580A patent/CA2980580C/en active Active
- 2016-03-23 SG SG11201707775TA patent/SG11201707775TA/en unknown
- 2016-03-23 EP EP21167900.6A patent/EP3869195B1/en active Active
- 2016-03-23 SG SG10201907918V patent/SG10201907918VA/en unknown
- 2016-03-23 WO PCT/US2016/023839 patent/WO2016154357A1/en active Application Filing
- 2016-03-23 CN CN201680029779.7A patent/CN107889507B/zh active Active
- 2016-03-23 PL PL16716342T patent/PL3274710T3/pl unknown
- 2016-03-23 EP EP16716342.7A patent/EP3274710B1/en active Active
- 2016-03-23 DK DK16716342.7T patent/DK3274710T3/da active
- 2016-03-23 AU AU2016235176A patent/AU2016235176B2/en active Active
- 2016-03-23 KR KR1020237030529A patent/KR20230132893A/ko active Search and Examination
- 2016-03-23 JP JP2017550191A patent/JP6902474B2/ja active Active
- 2016-03-23 US US15/560,584 patent/US11422125B2/en active Active
- 2016-03-23 HU HUE16716342A patent/HUE054946T2/hu unknown
- 2016-03-23 CA CA3188112A patent/CA3188112A1/en active Pending
- 2016-03-23 SG SG10201912315UA patent/SG10201912315UA/en unknown
- 2016-03-23 IL IL303401A patent/IL303401A/en unknown
- 2016-03-23 MX MX2017012259A patent/MX2017012259A/es unknown
- 2016-03-23 CN CN202111336261.7A patent/CN113930476A/zh active Pending
- 2016-03-23 KR KR1020177030540A patent/KR102577776B1/ko active IP Right Grant
- 2016-03-23 ES ES16716342T patent/ES2877400T3/es active Active
-
2017
- 2017-09-24 IL IL254617A patent/IL254617B/en unknown
- 2017-09-25 MX MX2022010736A patent/MX2022010736A/es unknown
-
2021
- 2021-06-21 JP JP2021102569A patent/JP7386206B2/ja active Active
-
2022
- 2022-08-15 US US17/887,783 patent/US11680941B2/en active Active
- 2022-08-17 AU AU2022218516A patent/AU2022218516A1/en active Pending
-
2023
- 2023-05-12 US US18/316,785 patent/US20230408489A1/en active Pending
- 2023-11-13 JP JP2023192860A patent/JP2024037720A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002364A1 (es) | Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas | |
CL2016002252A1 (es) | Anticuerpos anti-egfrviii y usos de los mismos | |
DK3207130T3 (da) | Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme | |
KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
BR112017004648A2 (pt) | simuladores mir-29 e os usos deste | |
DK3309174T3 (da) | ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf | |
DK3114145T3 (da) | Anti human interleukin-1-receptor-assessory-protein (il1rap) antistoffer og anvendelser deraf | |
CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
DK3286206T3 (da) | Hidtil ukendte hybride actriib-ligand-trap-proteiner til behandling af muskelsvindsygdomme | |
DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
CL2018001139A1 (es) | Anticuerpos anti-htra1 y métodos de uso de los mismos. | |
ZA201806436B (en) | Insecticidal proteins and methods for their use | |
DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
DK3274710T3 (da) | Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer | |
DK3137168T3 (da) | Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse | |
CL2016001921A1 (es) | Proteínas inmovilizadas y uso de las mismas | |
DK3506733T3 (da) | Dyrknings- og prøveudtagningsfremgangsmåde | |
DK3113153T3 (da) | Hybrid simulator og fremgangsmåde til at undervise i optik eller til at træne instilling af en optisk indretning | |
DK3110837T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formule-ringer og anvendelse deraf | |
GB201609952D0 (en) | Combined optical and mass spectral tissue ID probes | |
CL2017002226A1 (es) | Etv2 y usos de los mismos | |
DK3442944T3 (da) | Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider | |
BR112017012240A2 (pt) | métodos de preparação de composições contendo alcaloides e suas utilizações | |
BR112016021395A2 (pt) | métodos de geração de uma célula pluripotente e de preparação de uma célula ou tecido ensaio, uso de uma célula pluripotente, e, composição | |
DK3475310T3 (da) | Umættede derivater af polysaccharider, fremgangsmåder til fremstilling deraf og anvendelse deraf |